Leatt Corporation Announces Location of its Production Plant in Cape Town, South Africa

Leatt Brace Manufacturing (Pty) Ltd., a subsidiary of Leatt Brace Holdings (Pty) Ltd., has set up production facilities at a 10,764 square foot factory near the Killarney Race Track in Cape Town, South Africa. This production facility has been fitted with equipment which will facilitate the mass manufacture of Leatt-Braces™ as well as provide a location at which to conduct ongoing product testing via a Research and Development company, which will form part of the Leatt Brace Holdings (Pty) Ltd. Group. The R&D company uses a recently purchased computer accident simulation package that can accurately predict neck and brain forces, with and without a brace, and then assist with the final development of a particular brace structure. This cutting-edge technology will assist the Leatt Corporation in seeking to produce state-of-the-art products.

About The Leatt Corporation: The Leatt Corporation is the exclusive global distributor of the Leatt-Brace™, a Prophylactic Neck Brace designed to prevent potentially devastating motor sport injuries to the cervical spine (neck). The manufacture and development of the core products currently take place at the Leatt Corporation’s offices in Cape Town, South Africa, which are situated at the headquarters of the Leatt Brace Holdings (Pty) Ltd.

The Leatt-Brace™ is designed to prevent or lessen the severity of spine/neck injuries. The impetus for the project came from Dr. Chris Leatt’s medical knowledge, his history as a motorcycle racer and the many neck injuries he has witnessed. The product not only has motor sport applications, but the Company believes that it can be used by anyone wearing a crash helmet as a form of protection. The inventor of the brace, Dr. Chris Leatt, is the President of The Leatt Corporation and is responsible for executing the Company’s global strategy.

For more information on the Leatt-Brace™, please visit the company website at www.leatt-brace.com.

Legal Notice Regarding Forward-Looking Statements: This press release may contain forward-looking statements which are based on the Company's current expectations, forecasts and assumptions. In some cases forward-looking statements may be identified by forward-looking words like "would," "intend," "hope,"
"will," "may," "should," "expect," "anticipate," "believe," "estimate," "predict," "continue," or similar words. Forward-looking statements involve risks and uncertainties which could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the current economic climate and other risks and uncertainties, the limited resources of the Company and resulting vulnerability of the Company and its products to domestic and international competitors with considerably greater resources than the Company and possible inability to establish market share against competing products in many markets, current limited distribution channels for the Company’s products, actions of our competitors, the limited cash flow of the Company and the resulting reliance on the sale of Company securities to finance operations, the extent to which affects our ability to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our products, and changes in our business strategies. The Company’s common stock is traded on the Pink Sheet system and the Company is a “penny stock company” as defined under the rules of the Securities Exchange Act of 1934, as amended. As such, there are additional, substantial risks associated with the Company and its securities. Such risks include limited liquidity of the Company’s common stock and limitations on ability of broker-dealers to trade or recommend such stock.

Investor Relations: Please contact investorrelations@fastmail.fm or call +1 (702) 447-6751.